Ligand-clustered "patchy" nanoparticles for modulated cellular uptake and in vivo tumor targeting.
about
Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targetingUnderstanding Peptide Oligomeric State in Langmuir Monolayers of Amphiphilic 3-Helix Bundle-Forming Peptide-PEG Conjugates.A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumorsEGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells.Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Responsive linear-dendritic block copolymers.Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.Design of polymeric nanoparticles for biomedical delivery applications.Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeuticsEffect of ligand density, receptor density, and nanoparticle size on cell targetingOptimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers.Fluorescent multiblock π-conjugated polymer nanoparticles for in vivo tumor targeting.Treating metastatic cancer with nanotechnology.Multivalency as a chemical organization and action principle.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.PEGylated nanomedicines: recent progress and remaining concerns.Censored at the Nanoscale.Dendron-mediated self-assembly of highly PEGylated block copolymers: a modular nanocarrier platform.Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo.Polypeptide-Based Conjugates as Therapeutics: Opportunities and Challenges.A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release.Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents.Ligand-decorated click polypeptide derived nanoparticles for targeted drug delivery applicationsDrug delivery: One nanoparticle, one kill.The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy.A multiscale modeling study of particle size effects on the tissue penetration efficacy of drug-delivery nanoparticles.Fabrication of Bioactive Surfaces by Functionalization of Electroactive and Surface-Active Block Copolymers.Precision engineering of targeted nanocarriers.Fabrication of thermo-sensitive complex micelles for reversible cell targeting.RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors.Functional aqueous assemblies of linear-dendron hybridsVersatile multicompartment nanoparticles constructed with two thermo-responsive, pH-responsive and hydrolytic diblock copolymers
P2860
Q26785347-64B5BEF6-09FD-4A52-8A40-62BB5273BB1EQ30832384-35D787AE-D569-429D-91D0-F9E4796445DBQ33855309-F6BE5E0C-8D4D-47D2-B37B-D2EC5D6ED773Q34075391-93AE8AC2-E451-442C-9FAE-E766796C7687Q34281226-3B09D35A-74B3-4177-B8F8-66C6BC9D867BQ34447986-B1E30060-E774-40EF-9800-5412E3605F98Q35140625-AB84DFDF-D8C8-4D5F-B198-DF0FE869DDA4Q35142623-0DECEDC5-BD69-4E74-8AED-24DBC70C1652Q35823338-CB2AC8E0-DDE2-433B-AF7F-4819B367D6CFQ36035550-51A03B8F-570A-43D4-8E82-D5D5593FFA3DQ36413263-0CC9BB4A-E878-4FC4-854D-C3D115497742Q36869824-09146E31-7279-425B-8D68-70DCF69B00B3Q37726028-DDEF8163-A761-4F80-9727-F84C6BA0E2E5Q37970910-E9148089-DD1C-4FC7-AB51-9C49DC78E56BQ38041060-E912C3AB-853C-483F-9500-6B407A9044AFQ38067265-F414892D-25F8-43B3-BCF3-FD3F88EB893AQ38167826-5791E4E0-FB02-4C86-95B3-81A4C813ECF7Q38636432-A0CEFE59-E43F-420A-9895-5FAD1D9D04FEQ38672642-FD7CB839-7D38-4D8F-9290-EC7141B85A1BQ38757086-5CC8DB0D-8D9B-44EE-AE88-C3FDDB9418D5Q38983708-6A392463-9399-4AEF-BF22-E2A1E3F7ADF1Q39180899-811ADF29-6243-44DC-A049-A379A572875AQ39199893-00CD1641-DDDE-4C57-928D-BFFBA419D1C8Q42252410-27D7CDC4-0414-462E-8A3F-D687954A3CCDQ42862824-ED2BCBE3-5E2A-44B1-A8D8-A82DDD36F03AQ43564347-66EE4F8B-E136-4F50-923A-71EA770BD59AQ47163806-B49DDF10-F053-4A38-ABAC-9DB6419DAB5AQ49711598-8BC3F870-E554-448F-B589-63B7BE2BF470Q50049633-874AB09C-F62C-4C33-BEC5-B49E3285EB6EQ51693142-2B43E376-FD8E-4DA4-9D77-BA22B3BBB350Q52388109-4D9E803A-3067-49C8-9230-09D5C8D86D52Q57344870-72446026-2130-4D67-98FB-F48CF6F1B6AFQ57369480-B1CB9F7D-601C-4168-8295-FA61B164F0BA
P2860
Ligand-clustered "patchy" nanoparticles for modulated cellular uptake and in vivo tumor targeting.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Ligand-clustered "patchy" nano ...... e and in vivo tumor targeting.
@ast
Ligand-clustered "patchy" nano ...... e and in vivo tumor targeting.
@en
type
label
Ligand-clustered "patchy" nano ...... e and in vivo tumor targeting.
@ast
Ligand-clustered "patchy" nano ...... e and in vivo tumor targeting.
@en
prefLabel
Ligand-clustered "patchy" nano ...... e and in vivo tumor targeting.
@ast
Ligand-clustered "patchy" nano ...... e and in vivo tumor targeting.
@en
P2093
P2860
P356
P1476
Ligand-clustered "patchy" nano ...... e and in vivo tumor targeting.
@en
P2093
Amanda C Engler
Evrim Atas
Geoffrey von Maltzahn
Hyung-il Lee
Sangeeta N Bhatia
Shujun Chen
P2860
P304
P356
10.1002/ANIE.201003445
P407
P577
2010-09-01T00:00:00Z